GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeaStar Medical Holding Corp (NAS:ICU) » Definitions » Price-to-Free-Cash-Flow

ICU (SeaStar Medical Holding) Price-to-Free-Cash-Flow : N/A (As of Apr. 12, 2025)


View and export this data going back to 2022. Start your Free Trial

What is SeaStar Medical Holding Price-to-Free-Cash-Flow?

As of today (2025-04-12), SeaStar Medical Holding's share price is $1.31. SeaStar Medical Holding's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-4.37. Hence, SeaStar Medical Holding's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for SeaStar Medical Holding's Price-to-Free-Cash-Flow or its related term are showing as below:

ICU's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 27.73
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

SeaStar Medical Holding's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-0.95. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-4.37.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 24.80% per year.

During the past 5 years, SeaStar Medical Holding's highest 3-Year average Free Cash Flow per Share Growth Rate was 24.80% per year. The lowest was -2.60% per year. And the median was 11.10% per year.


SeaStar Medical Holding Price-to-Free-Cash-Flow Historical Data

The historical data trend for SeaStar Medical Holding's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeaStar Medical Holding Price-to-Free-Cash-Flow Chart

SeaStar Medical Holding Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
- - - - -

SeaStar Medical Holding Quarterly Data
Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SeaStar Medical Holding's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, SeaStar Medical Holding's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeaStar Medical Holding's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where SeaStar Medical Holding's Price-to-Free-Cash-Flow falls into.


;
;

SeaStar Medical Holding Price-to-Free-Cash-Flow Calculation

SeaStar Medical Holding's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.31/-4.371
=N/A

SeaStar Medical Holding's Share Price of today is $1.31.
SeaStar Medical Holding's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

SeaStar Medical Holding  (NAS:ICU) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


SeaStar Medical Holding Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of SeaStar Medical Holding's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


SeaStar Medical Holding Business Description

Traded in Other Exchanges
N/A
Address
3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
Executives
Kevin Chung officer: Chief Medical Officer C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Heel Kenneth Van director C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Richard D. Russell director 3201 W BAY VISTA AVE, TAMPA FL 33611
Bruce M. Rodgers director 302 KNIGHTS RUN AVE., STE. 1000, TAMPA FL 33602
Andres Lobo director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Caryl Baron officer: See Remarks C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Eric Schlorff director, officer: Chief Executive Officer C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Rick Barnett director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Allan Collins director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Dow Employees' Pension Plan Trust 10 percent owner 2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Union Carbide Employees' Pension Plan Trust 10 percent owner 2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Martin A Traber director 100 N TAMPA STREET, SUITE 2700, TAMPA FL 33602
Lm Funding America, Inc. 10 percent owner 1200 WEST PLATT STREET, SUITE 100, TAMPA FL 33606
Craig E Burson director 400 N. PARK AVENUE, UNIT 10B, BRECKENRIDGE CO 80424
Bruce H Bennett director 3929 ARLINGTON DRIVE, PALM HARBOR FL 34685

SeaStar Medical Holding Headlines